Repeat nephron-sparing surgery for children with bilateral Wilms tumor

J Pediatr Surg. 2014 Jan;49(1):149-53. doi: 10.1016/j.jpedsurg.2013.09.048. Epub 2013 Oct 5.

Abstract

Background: Renal insufficiency is a significant complication of Wilms tumor treatment in the 5% with bilateral disease. Nephron-sparing surgery (NSS) is recommended after neoadjuvant chemotherapy initially. However, the role of NSS in recurrent disease is unknown. We reviewed our experience to assess the feasibility and oncologic and functional outcomes of repeat NSS for children with recurrent disease.

Methods: A retrospective review was performed of all children treated at our institution for bilateral, favorable histology (FH) Wilms tumor. Patients undergoing repeat NSS for locally recurrent disease were identified. The outcomes evaluated included tumor recurrence, renal function, and patient survival.

Results: Since 2001, 36 children with bilateral FH Wilms tumor have been treated at our institution. Eight patients (22%) underwent repeat NSS for locally recurrent disease. Two patients had a second local recurrence and underwent a third NSS. Six patients are alive without disease (75%) with an average follow-up of 4.5years. Two patients have died, each with blastemal-predominant histology at repeat NSS. The surviving patients have normal renal function, although two patients require medical management of hypertension.

Conclusions: Our experience suggests that repeat NSS for local recurrence of FH bilateral Wilms tumor is feasible and affords acceptable oncologic outcome with preservation of renal function. However, more aggressive therapy may be required for patients whose recurrence has blastemal-predominant histology, given the poor outcome for these patients in our series.

Keywords: Hypertension; Nephron-sparing surgery; Recurrence; Renal failure; Wilms tumor.

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Child, Preschool
  • Combined Modality Therapy
  • Dactinomycin / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Kidney Failure, Chronic / prevention & control
  • Kidney Neoplasms / drug therapy
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / surgery*
  • Male
  • Neoadjuvant Therapy
  • Neoplasm Recurrence, Local / surgery*
  • Neoplasms, Multiple Primary / drug therapy
  • Neoplasms, Multiple Primary / pathology
  • Neoplasms, Multiple Primary / surgery*
  • Nephrectomy / methods*
  • Nephrons / surgery
  • Organ Sparing Treatments / methods*
  • Postoperative Complications / prevention & control
  • Prognosis
  • Reoperation
  • Retrospective Studies
  • Survival Analysis
  • Treatment Outcome
  • Vinblastine / administration & dosage
  • Wilms Tumor / drug therapy
  • Wilms Tumor / pathology
  • Wilms Tumor / surgery*

Substances

  • Dactinomycin
  • Vinblastine
  • Doxorubicin